LW-1017, an oral drug that switches the brain’
Browsing: All news
Category Added in a WPeMatico Campaign
One-year results for the open-chest version look
Amorepacific deal puts therapeutic target discov
AbbVie announced that the FDA has approved Juvmo
Arvinas announced that the first participant has
4DMT has enrolled first patients in its 4SIGHT gl
A further $173 billion a year is real on paper – but only once three separate regulatory clocks finish running down. With thanks to MuseCell Innovations, sponsor of the Longevity Biotech Report. The $230 billion pipeline needs nothing from anyone.…
The 4th Roundtable of Longevity Clinics meets at
Resolution Therapeutics has treated its last EME
Slow-release apomorphine patch just passed first